Physicians’ Experience and Willingness to Participate in Non-Interventional Trials in Bulgaria

Author:

Kostov Emil S.1,Grigorov Evgeni E.2,Lebanova Hristina V.3

Affiliation:

1. Medical College, Medical University - Pleven

2. Faculty of Pharmacy , Medical University - Varna

3. Faculty of Pharmacy , Medical University - Pleven

Abstract

Summary Non-interventional studies (NIS) are conducted to obtain additional information about a medicinal product prescribed in the usual manner in compliance with the conditions determined in the marketing authorization. They are a valuable source of real-world data for the effectiveness and safety of medicines. This study aims to assess physicians‘ knowledge of non-interventional studies in Bulgaria and identify the primary factors and barriers hindering the NIS at a national level. An individual anonymous questionnaire with 16 items was distributed among physicians in inpatient and outpatient settings. The results showed that 81.3% (n=147) of the respondents have no experience with non-interventional studies. Physicians‘ willingness to participate in NIS in the future is high and independent of their previous experience. The main barriers hindering conducting NIS in Bulgaria are related to organization, the conduct and the design of the trials, and, sometimes, the investigators‘ concerns. There is a need for proper training of the researchers and expanding healthcare resources to grow the NIS sector in Bulgaria in line with the tendencies in Europe.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Reference11 articles.

1. 1. Medicinal Products in Human Medicine Act. https://www.mh.government.bg/media/filer_public/2021/03/08/zakon_za_lekarstvenite_produkti_v_humannata_medicina.pdf.

2. 2. ClinicalTrials.gov. Trends, Charts, and Maps - ClinicalTrials.gov. Web. 2018. https://clinicaltrials.gov/ct2/resources/trends#TypesOfRegisteredStudies. Accessed 4 April 2021.

3. 3. EC. Regulation (EU) No 536/2014 of the European Parliament and of The Council of 16 April 2014 on clinical trials on medicinal products for human use. 2014 https://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX:32014R0536.

4. 4. SAS Institute Inc. SAS/STAT. 2011.

5. 5. 5. Ibe OC. Introduction to Descriptive Statistics. In: Fundamentals of Applied Probability and Random Processes. 2014:253–74.10.1016/B978-0-12-800852-2.00008-0

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3